<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371826">
  <stage>Registered</stage>
  <submitdate>10/11/2016</submitdate>
  <approvaldate>3/08/2017</approvaldate>
  <actrnumber>ACTRN12617001137381</actrnumber>
  <trial_identification>
    <studytitle>Asymptomatic Increased endometrial thickness in postmenopausal women .risk factors</studytitle>
    <scientifictitle>Asymptomatic increased endometrial thickness in postmenopausal women: risk factors</scientifictitle>
    <utrn>U1111-1189-6844</utrn>
    <trialacronym>None</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>risk factors causing increased endometrial thickness in post menopause</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Menstruation and menopause</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This study is evaluating the hypothesis that, there are some factors causing increased the endometrium thickness in some asymptomatic postmenopausal women that carried increased risk of cellular changes. Histopathology will be done for cases with increased thickness.40 minutes consultation at baseline visit .</interventions>
    <comparator> 73 women  in each group of asymptomatic post-menopause women will be recruited ,Women will be divided according to endometrial thickness into:
           Group (A): those having 5 mm endometrial thickness or more .
           Group (B): those having less than 5 mm endometrial thickness  .                                                                                                                                                                                                                                                                
</comparator>
    <control>Active</control>
    <interventioncode>Early Detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The variation in ET measured by trans-vaginal ultrasound </outcome>
      <timepoint>they will be checked at once  at baseline visit.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The variation in ET with respect to presence of myoma by using trans-vaginal ultrasound    .</outcome>
      <timepoint>once at baseline </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The variation in ET with respect to uterine volume by using trans-vaginal ultrasound    .</outcome>
      <timepoint>once at baseline</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Postmenopausal women.
No vaginal bleeding.
Intact uterus.
</inclusivecriteria>
    <inclusiveminage>45</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Women with gynecological symptoms e.g. vaginal bleeding, bloody discharge 
Women underwent gynecological operation e.g. hysterectomy or recent D&amp;C.
Women with ovarian or endometrium or cervical cancer.
Patients under hormonal therapy
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>(73 in each arm, asymptomatic post-menopause women will be recruited according to G.Power 3.0.10 software sample size calculator assuming that Effect size d	=0.5, a err prob=	0.05, Power (1-Beta err prob) =0.85, Allocation ratio N2/N1	=1</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>8/10/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>146</samplesize>
    <actualsamplesize />
    <currentsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>31/10/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Cairo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>nahed allam</primarysponsorname>
    <primarysponsoraddress>AlAzhar unversity hospital for girls
4 Dawood Barakat street ,Nasr city 
Cairo
 Egypt</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>alzahraa university hospital</fundingname>
      <fundingaddress>Elmostashfa elyuonany street,Abassia,cairo</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Taaiseer Maarouf</sponsorname>
      <sponsoraddress>Alzhraa university hospital
Elmostashfa elyuonany street,Abassia,cairo
postcode 11651</sponsoraddress>
      <sponsorcountry>Egypt</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Study hypothesis: 
This study suggests that there are some factors causing increased the endometrium thickness in some asymptomatic postmenopausal women that carried increased risk of cellular changes.characterization of those patient could help to pick up risky patients for endometrial cancer.
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethical committee of the Department of gynecology and obstetrics, Faculty of Medicine, AL-Azhar University</ethicname>
      <ethicaddress>4 Dawood Barakat street ,nasr city ,
Cairo
Egypt</ethicaddress>
      <ethicapprovaldate>3/07/2016</ethicapprovaldate>
      <hrec>7833014</hrec>
      <ethicsubmitdate>8/05/2016</ethicsubmitdate>
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Nahed Ezzat Allam</name>
      <address>AlAzhar university hospital for girls
4 Dawood Barakat sreet,nasr city,cairo</address>
      <phone>+201229121089</phone>
      <fax />
      <email>nahedallam16@gmail.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Nahed Ezzat Allam</name>
      <address>Alzahraa university hospital
5 Alyonani hospital street
Abasia ,Cairo
Egypt</address>
      <phone>+201229121089</phone>
      <fax />
      <email>nahedallam16@gmail.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Taiseer Maarouf</name>
      <address>Alzahraa university hospital
5 Alyonani hospital street
Abasia ,Cairo
Egypt</address>
      <phone>+201229121089</phone>
      <fax />
      <email>nahedallam16@gmail.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Nahed Ezzat Allam</name>
      <address>Alzahraa university hospital
5 Alyonani hospital street
Abasia ,Cairo
Egypt</address>
      <phone>+201229121089</phone>
      <fax />
      <email>nahedallam16@gmail.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>